Goldman Sachs
SBRA icon

Goldman Sachs’s Sabra Healthcare REIT SBRA Stock Holding History

Goldman Sachs’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.8M Buy
3,733,941
+1,253,365
+51% +$24.7M 0.01% 1280
2025
Q4 		$47M Buy
2,480,576
+985,211
+66% +$18.3M 0.01% 1554
2025
Q3 		$27.9M Buy
1,495,365
+65,162
+5% +$1.22M ﹤0.01% 1928
2025
Q2 		$26.4M Sell
1,430,203
-470,945
-25% -$8.36M ﹤0.01% 1876
2025
Q1 		$33.2M Sell
1,901,148
-579,003
-23% -$9.76M 0.01% 1554
2024
Q4 		$43M Buy
2,480,151
+793,927
+47% +$14.5M 0.01% 1432
2024
Q3 		$31.4M Buy
1,686,224
+665,068
+65% +$11.2M 0.01% 1651
2024
Q2 		$15.7M Sell
1,021,156
-203,571
-17% -$2.91M ﹤0.01% 2076
2024
Q1 		$18.1M Buy
1,224,727
+92,209
+8% +$1.28M ﹤0.01% 1938
2023
Q4 		$16.2M Sell
1,132,518
-85,644
-7% -$1.22M ﹤0.01% 2104
2023
Q3 		$17M Sell
1,218,162
-152,367
-11% -$1.95M ﹤0.01% 1950
2023
Q2 		$16.1M Buy
1,370,529
+440,319
+47% +$5.01M ﹤0.01% 2032
2023
Q1 		$10.7M Buy
930,210
+502,585
+118% +$6.22M ﹤0.01% 2358
2022
Q4 		$5.32M Sell
427,625
-1,049,860
-71% -$13.4M ﹤0.01% 3113
2022
Q3 		$19.4M Buy
1,477,485
+776,802
+111% +$11.5M ﹤0.01% 1895
2022
Q2 		$9.79M Sell
700,683
-4,786,268
-87% -$64M ﹤0.01% 2539
2022
Q1 		$81.7M Buy
5,486,951
+384,092
+8% +$5.26M 0.02% 890
2021
Q4 		$69.1M Buy
5,102,859
+603,623
+13% +$8.54M 0.01% 1071
2021
Q3 		$66.2M Buy
4,499,236
+1,415,791
+46% +$23.9M 0.01% 1049
2021
Q2 		$56.1M Buy
3,083,445
+2,166,575
+236% +$38.6M 0.01% 1153
2021
Q1 		$15.9M Sell
916,870
-1,645,912
-64% -$28.9M ﹤0.01% 2135
2020
Q4 		$44.5M Sell
2,562,782
-275,005
-10% -$4.39M 0.01% 1205
2020
Q3 		$39.1M Buy
2,837,787
+716,549
+34% +$10.5M 0.01% 1184
2020
Q2 		$30.6M Sell
2,121,238
-241,899
-10% -$3.18M 0.01% 1341
2020
Q1 		$25.8M Buy
2,363,137
+1,094,908
+86% +$20.2M 0.01% 1332
2019
Q4 		$27.1M Buy
1,268,229
+506,691
+67% +$11.3M 0.01% 1612
2019
Q3 		$17.5M Sell
761,538
-264,704
-26% -$5.65M 0.01% 1885
2019
Q2 		$20.2M Buy
1,026,242
+247,889
+32% +$4.83M 0.01% 1848
2019
Q1 		$15.2M Sell
778,353
-1,096,434
-58% -$20.8M ﹤0.01% 2104
2018
Q4 		$30.9M Buy
1,874,787
+384,749
+26% +$7.75M 0.01% 1462
2018
Q3 		$34.5M Sell
1,490,038
-232,216
-13% -$5.26M 0.01% 1491
2018
Q2 		$37.4M Buy
1,722,254
+455,703
+36% +$8.9M 0.01% 1436
2018
Q1 		$22.4M Buy
1,266,551
+80,630
+7% +$1.42M 0.01% 1772
2017
Q4 		$22.3M Sell
1,185,921
-414,055
-26% -$8.24M 0.01% 1859
2017
Q3 		$35.1M Buy
1,599,976
+974,346
+156% +$22M 0.01% 1533
2017
Q2 		$15.1M Buy
625,630
+462,918
+285% +$11.8M ﹤0.01% 2185
2017
Q1 		$4.54M Buy
162,712
+8,667
+6% +$227K ﹤0.01% 3013
2016
Q4 		$3.76M Sell
154,045
-88,958
-37% -$2.04M ﹤0.01% 3302
2016
Q3 		$6.12M Buy
243,003
+64,152
+36% +$1.54M ﹤0.01% 2871
2016
Q2 		$3.69M Buy
178,851
+87,410
+96% +$1.82M ﹤0.01% 3110
2016
Q1 		$1.84M Sell
91,441
-33,599
-27% -$644K ﹤0.01% 3565
2015
Q4 		$2.53M Buy
125,040
+36,733
+42% +$774K ﹤0.01% 3431
2015
Q3 		$2.05M Buy
88,307
+10,603
+14% +$271K ﹤0.01% 3770
2015
Q2 		$2M Buy
77,704
+7,251
+10% +$206K ﹤0.01% 3819
2015
Q1 		$2.33M Buy
70,453
+5,855
+9% +$190K ﹤0.01% 3630
2014
Q4 		$1.96M Buy
64,598
+31,178
+93% +$859K ﹤0.01% 3862
2014
Q3 		$812K Buy
33,420
+8,296
+33% +$230K ﹤0.01% 4810
2014
Q2 		$721K Sell
25,124
-19,244
-43% -$559K ﹤0.01% 5013
2014
Q1 		$1.24M Sell
44,368
-85,897
-66% -$2.36M ﹤0.01% 4460
2013
Q4 		$3.4M Buy
130,265
+73,341
+129% +$1.89M ﹤0.01% 3508
2013
Q3 		$1.31M Buy
56,924
+29,108
+105% +$717K ﹤0.01% 4344
2013
Q2 		$726K Buy
+27,816
New +$803K ﹤0.01% 4645

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs's SBRA Position: Q1 2026 in Review

Goldman Sachs increased its Sabra Healthcare REIT (SBRA) stake by 51% in Q1 2026, buying an estimated $24.7M and bringing the position to 3,733,941 shares worth $71.8M. The position accounts for 0.01% of the portfolio, ranked #1280.

Goldman Sachs first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.7M in Q1 2022. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Goldman Sachs held 3,733,941 shares of Sabra Healthcare REIT worth $71.8M as of Q1 2026.
  • Goldman Sachs bought 1,253,365 Sabra Healthcare REIT shares in Q1 2026, an estimated $24.7M.
  • Sabra Healthcare REIT made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1280 holding.
  • Goldman Sachs first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Sabra Healthcare REIT position peaked at $81.7M in Q1 2022.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.